Tumor cell response to bevacizumab single agent therapy in vitro

BACKGROUND: Angiogenesis represents a highly multi-factorial and multi-cellular complex (patho-) physiologic event involving endothelial cells, tumor cells in malignant conditions, as well as bone marrow derived cells and stromal cells. One main driver is vascular endothelial growth factor (VEGFA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Hein, Melanie, Graver, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849065/
https://www.ncbi.nlm.nih.gov/pubmed/24059699
http://dx.doi.org/10.1186/1475-2867-13-94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849065/
https://www.ncbi.nlm.nih.gov/pubmed/24059699
http://dx.doi.org/10.1186/1475-2867-13-94

Ejemplares similares